GRLS
10.9084 EUR
+0.28%
Today
-0.23%
1D
Last seen at Wed, 25 Feb 2026 14:27:00 GMT+3
Market is open
Sun
Closed
Mon
10:01 AM ~ 6:30 PM
Tue
10:01 AM ~ 6:30 PM
Wed
10:01 AM ~ 6:30 PM
Thu
10:01 AM ~ 6:30 PM
Fri
10:01 AM ~ 6:30 PM
Sat
Closed
Performance
1 Day
- 0.23 %
1 Week
- 0.61 %
1 Month
- 0.43 %
3 Month
+ 6.45 %
6 Month
- 10.73 %
1 Year
+ 15.08 %
Information
Name
Grifols Leveraged ( Spain )
Currency
EUR
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0137%
Overnight Fees Sell
-0.0030%
Market Cap
7.19B
Avg Daily Volume
1.22M
52 Week High
13.7 EUR
52 Week Low
7.324 EUR
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01370% | $(0.137) |
| SELLS | -0.00300% | $(0.030) |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It also markets diagnostic testing equipment, reagents, and other equipment; offers biological products and manufacturing services; and manufactures and sells plasma to third parties. In addition, the company offers Yimmugo IDP, an immunology drug; Yimmugo PTI, a hematology drug; and Prolastin vials, a pulmonology drug. Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, Fibrinogen, and VISTASEAL; Prolastin-C AADT and Fostamatinib; Xembify CLL, Albumina 20% and 5%, and Trimodulin; Alfa-1 AT 15%, GRF6019, GRF6021, Aßvac402, AKST4290, and AKST4290; GIGA 2339 and GIGA564; and recIG, Alfa-1 AT - in non-cystic fibrosis bronchiectasis, and OSIG that are in pre-clinical stage. It has collaboration agreements with Canadian Blood Services to supply grains of Immunoglobulin. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Top News
Grifols
-0.23%
CORRECTED-Grifols says on course to meet 2025 outlook as net profit triples
reuters.com
9mo ago
Frequently Asked Questions
What defines retail stocks?
Retail stocks represent businesses that sell goods directly to consumers, including brick-and-mortar stores, e-commerce platforms, and consumer brands.
Are retail stocks seasonal?
Yes. Sales tend to spike during holidays and promotional periods like Black Friday, which can significantly impact quarterly earnings.
What factors influence retail stock performance?
Consumer confidence, inflation, disposable income, and trends in online shopping all play major roles in retail stock movements.
Is the retail sector considered risky?
It can be, due to changing consumer behavior, competition from e-commerce, and sensitivity to economic conditions like interest rates and employment levels.
